NBVM GP LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-09 4:20 pm Purchase | 2023-05-31 | 13D | Lyra Therapeutics, Inc. LYRA | NBVM GP LLC | 6,031,468 12.200% | 1,812,666 (+42.97%) | Filing |
| 2022-04-22 4:20 pm Purchase | 2022-04-12 | 13D | Lyra Therapeutics, Inc. LYRA | NBVM GP LLC | 4,218,802 13.200% | 2,504,865 (+146.15%) | Filing |
| 2020-05-15 4:58 pm Purchase | 2020-05-05 | 13D | Lyra Therapeutics, Inc. LYRA | NBVM GP LLC | 1,713,937 13.300% | 1,713,937 (New Position) | Filing |